Ontology highlight
ABSTRACT: Background
In older people, chronological age may not be the best predictor of residual lifespan and mortality, because with age the heterogeneity in health is increasing. Biomarkers for biological age and residual lifespan are being developed to predict disease and mortality better at an individual level than chronological age. In the current paper, we aim to classify a group of older people into those with longevity potential or controls.Methods
In the Leiden Longevity Study participated 1671 offspring of nonagenarian siblings, as the group with longevity potential, and 744 similarly aged controls. Using known risk factors for cardiovascular disease, previously reported markers for human longevity and other physiological measures as predictors, classification models for longevity potential were constructed with multiple logistic regression of the offspring-control status.Results
The Framingham Risk Score (FRS) is predictive for longevity potential [area under the receiver operating characteristic curve (AUC) = 64.7]. Physiological parameters involved in immune responses and glucose, lipid and energy metabolism further improve the prediction performance for longevity potential (AUCmale = 71.4, AUCfemale = 68.7).Conclusion
Using the FRS, the classification of older people in groups with longevity potential and controls is moderate, but can be improved to a reasonably good classification in combination with markers of immune response, glucose, lipid, and energy metabolism. We show that individual classification of older people for longevity potential may be feasible using biomarkers from a wide variety of different biological processes.
SUBMITTER: Beekman M
PROVIDER: S-EPMC5083840 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Beekman Marian M Uh Hae-Won HW van Heemst Diana D Wuhrer Manfred M Ruhaak L Renee LR Gonzalez-Covarrubias Vanessa V Hankemeier Thomas T Houwing-Duistermaat Jeanine J JJ Slagboom P Eline PE
Frontiers in public health 20161028
<h4>Background</h4>In older people, chronological age may not be the best predictor of residual lifespan and mortality, because with age the heterogeneity in health is increasing. Biomarkers for biological age and residual lifespan are being developed to predict disease and mortality better at an individual level than chronological age. In the current paper, we aim to classify a group of older people into those with longevity potential or controls.<h4>Methods</h4>In the Leiden Longevity Study pa ...[more]